关注
Kate Diana Lynch
Kate Diana Lynch
Royal Adelaide Hospital
在 sa.gov.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
The UK‐PBC risk scores: derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis
M Carbone, SJ Sharp, S Flack, D Paximadas, K Spiess, C Adgey, ...
Hepatology 63 (3), 930-950, 2016
3832016
Performance of the Glasgow-Blatchford score in predicting clinical outcomes and intervention in hospitalized patients with upper GI bleeding
RV Bryant, P Kuo, K Williamson, C Yam, MN Schoeman, RH Holloway, ...
Gastrointestinal endoscopy 78 (4), 576-583, 2013
1642013
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score
M Carbone, A Nardi, S Flack, G Carpino, N Varvaropoulou, C Gavrila, ...
The lancet Gastroenterology & hepatology 3 (9), 626-634, 2018
1332018
A novel prognostic model for transplant-free survival in primary sclerosing cholangitis
EM de Vries, J Wang, KD Williamson, MM Leeflang, K Boonstra, ...
Gut 67 (10), 1864-1869, 2018
1192018
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: an international cohort study
EMG de Vries, M de Krijger, M Färkkilä, J Arola, P Schirmacher, ...
Hepatology 65 (3), 907-919, 2017
942017
Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases
KD Lynch, RW Chapman, S Keshav, AJ Montano-Loza, AL Mason, ...
Clinical gastroenterology and hepatology 18 (1), 179-187. e6, 2020
852020
Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system
EC Goode, AB Clark, GF Mells, B Srivastava, K Spiess, WTH Gelson, ...
Hepatology 69 (5), 2120-2135, 2019
802019
Obeticholic acid—a new therapy in PBC and NASH
RW Chapman, KD Lynch
British medical bulletin 133 (1), 95-104, 2020
702020
Primary sclerosing cholangitis: a clinical update
KD Williamson, RW Chapman
British medical bulletin 114 (1), 53-64, 2015
662015
New therapeutic strategies for primary sclerosing cholangitis
KD Williamson, RW Chapman
Seminars in liver disease 36 (01), 005-014, 2016
622016
Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells
NM Provine, B Binder, MEB FitzPatrick, A Schuch, LC Garner, ...
Frontiers in immunology 9, 756, 2018
592018
Lymphocyte activation gene (LAG)-3 is associated with mucosal inflammation and disease activity in ulcerative colitis
SM Slevin, LC Garner, C Lahiff, M Tan, LM Wang, H Ferry, B Greenaway, ...
Journal of Crohn's and Colitis 14 (10), 1446-1461, 2020
352020
Are dominant strictures in primary sclerosing cholangitis a risk factor for cholangiocarcinoma?
RW Chapman, KD Williamson
Current hepatology reports 16, 124-129, 2017
302017
Effects of tumor necrosis factor antagonists in patients with primary sclerosing cholangitis
CRH Hedin, G Sado, N Ndegwa, E Lytvyak, A Mason, A Montano-Loza, ...
Clinical gastroenterology and hepatology 18 (10), 2295-2304. e2, 2020
292020
The use of biologics in patients with inflammatory bowel disease and primary sclerosing cholangitis
KD Lynch, S Keshav, RW Chapman
Current hepatology reports 18, 115-126, 2019
272019
further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC.
KD Williamson, RW Chapman
Alimentary pharmacology & therapeutics 41 (1), 149-151, 2015
202015
Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications
SP Yeap, H Harley, R Thompson, KD Williamson, J Bate, F Sethna, ...
Journal of Gastroenterology and Hepatology 34 (2), 425-435, 2019
122019
International Primary Sclerosing Cholangitis Study Group (IPSCSG), Levy C. Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
KD Lynch, RW Chapman, S Keshav, AJ Montano-Loza, AL Mason, ...
Clin Gastroenterol Hepatol 18 (1), 179-187, 2020
92020
Clinical triage for colonoscopy is useful in young women
KD Williamson, K Steveling, G Holtmann, M Schoeman, JM Andrews
Internal Medicine Journal 45 (5), 492-496, 2015
82015
Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study
N Tan, N Ngu, T Worland, T Lee, T Abrahams, K Pandya, E Freeman, ...
Hepatology International 16 (5), 1094-1104, 2022
72022
系统目前无法执行此操作,请稍后再试。
文章 1–20